{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:43:38Z","timestamp":1788241418073,"version":"build-2803163510"},"reference-count":55,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bumsuk Academic Research Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Although there have been several studies regarding the immunogenicity of one or two booster doses of the measles\u2013mumps\u2013rubella (MMR) vaccine in measles-seronegative young adults, limited data are available about how long the immune response is sustained compared with natural infection. This study included seronegative healthcare workers (HCWs) (aged 21\u201338 years) who received one or two doses of the measles\u2013mumps\u2013rubella (MMR) vaccine and HCWs with laboratory-confirmed measles infection during an outbreak in 2019. We compared neutralizing antibody titers measured using the plaque reduction neutralization (PRN) test and measles-specific immunoglobulin G (IgG) using chemiluminescent immunoassays 2 years after vaccination or infection. Among 107 HCWs with seronegative measles IgGs, the overall seroconversion rate of measles IgGs remained 82.2% (88\/107), and 45.8% (49\/107) of the participants had a medium (121\u2013900) or high (&gt;900) PRN titer after 2 years from one or two booster doses. The measles-neutralizing antibody titers of both PRN titer (ND50) and geometric mean concentration 2 years after natural infection were significantly higher than those of one or two booster doses of the MMR vaccine (p &lt; 0.001 and p &lt; 0.001, respectively). Our results suggest that serologic screening followed by appropriate postexposure prophylaxis can be beneficial for young HCWs without a history of natural infection especially in a measles outbreak setting, because of possible susceptibility to measles despite booster MMR vaccination 2 years ago. Long-term data about sustainable humoral immunity after one or two booster vaccination are needed based on the exact vaccination history.<\/jats:p>","DOI":"10.3390\/vaccines10111812","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T10:47:57Z","timestamp":1667126877000},"page":"1812","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Measles Virus Neutralizing Antibody Response and Durability Two Years after One or Two Doses of Measles\u2013Mumps\u2013Rubella Vaccine among Young Seronegative Healthcare Workers"],"prefix":"10.3390","volume":"10","author":[{"given":"Byungki","family":"Jang","sequence":"first","affiliation":[{"name":"Ilsong Institute of Life Science, Hallym University, Seoul 01000, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Wool","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14100, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Sung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14100, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Young","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14100, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6659-6853","authenticated-orcid":false,"given":"Hyeonji","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14100, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Kyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14100, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(21)02004-3","article-title":"Measles","volume":"399","author":"Dina","year":"2022","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cmi.2017.01.003","article-title":"Measles and Rubella Elimination in the WHO Region for Europe: Progress and Challenges","volume":"23","author":"Jankovic","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1016\/S2214-109X(18)30492-3","article-title":"Classification of Global Measles Cases in 2013-17 as Due to Policy or Vaccination Failure: A Retrospective Review of Global Surveillance Data","volume":"7","author":"Patel","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1016\/j.vaccine.2017.06.058","article-title":"An Increasing, Potentially Measles-Susceptible Population over Time after Vaccination in Korea","volume":"35","author":"Kang","year":"2017","journal-title":"Vaccine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/infdis\/jis568","article-title":"Waning Antibody Levels and Avidity: Implications for MMR Vaccine-Induced Protection","volume":"206","author":"Kontio","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1017\/S0950268813002859","article-title":"Healthcare Workers and Measles-Mumps-Rubella (MMR) Status: How Worried Should We Be about Further Outbreaks?","volume":"142","author":"Basu","year":"2014","journal-title":"Epidemiol. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jhin.2013.01.002","article-title":"Measles Immunity and Measles Vaccine Acceptance among Healthcare Workers in Paris, France","volume":"84","author":"Freund","year":"2013","journal-title":"J. Hosp. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3947\/ic.2019.51.1.58","article-title":"Seroprevalence of Measles in Healthcare Workers in South Korea","volume":"51","author":"Jung","year":"2019","journal-title":"Infect. Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1016\/j.vaccine.2012.04.023","article-title":"Nosocomial Transmission of Measles: An Updated Review","volume":"30","author":"Gautret","year":"2012","journal-title":"Vaccine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1016\/j.vaccine.2014.03.097","article-title":"Healthcare Providers as Sources of Vaccine-Preventable Diseases","volume":"32","author":"Sydnor","year":"2014","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1016\/j.vaccine.2019.09.061","article-title":"Vaccination of Healthcare Personnel in Europe: Update to Current Policies","volume":"37","author":"Maltezou","year":"2019","journal-title":"Vaccine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1016\/j.vaccine.2017.11.077","article-title":"A Third Dose of Measles Vaccine Is Needed in Young Korean Health Care Workers","volume":"36","author":"Kim","year":"2018","journal-title":"Vaccine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3947\/ic.2021.0084","article-title":"Report of the Korean Society of Infectious Diseases Roundtable Discussion on Responses to the Measles Outbreaks in Korea in 2019","volume":"53","author":"Seok","year":"2021","journal-title":"Infect. Chemother."},{"key":"ref_14","unstructured":"Advisory Committee on Immunization Practices, and Centers for Disease Control and Prevention (CDC) (2011). Immunization of Health-Care Personnel: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep., 60, 1\u201345."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/infdis\/jiv555","article-title":"Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity before and after Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults","volume":"213","author":"Fiebelkorn","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1080\/21645515.2021.1888623","article-title":"Measles Seroprevalence among Healthcare Workers in South Korea during the Post-Elimination Period","volume":"17","author":"Han","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/infdis\/jiz508","article-title":"Long-Term Immunogenicity of Measles Vaccine: An Italian Retrospective Cohort Study","volume":"221","author":"Bianchi","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kim, C.-J., Bae, J.-Y., Jun, K.-I., Chung, H.-S., Kim, A., Kim, J., Son, H.-J., Lee, M., and Choi, H.-J. (2021). Risk of Absence of Measles Antibody in Healthcare Personnel and Efficacy of Booster Vaccination. Vaccines, 9.","DOI":"10.3390\/vaccines9050501"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10096-021-04390-4","article-title":"Control of a Nosocomial Measles Outbreak among Previously Vaccinated Adults in a Population with High Vaccine Coverage: Korea, 2019","volume":"41","author":"Song","year":"2022","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vaccine.2007.10.046","article-title":"Plaque Reduction Neutralization Test for Measles Antibodies: Description of a Standardised Laboratory Method for Use in Immunogenicity Studies of Aerosol Vaccination","volume":"26","author":"Cohen","year":"2007","journal-title":"Vaccine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jviromet.2005.08.001","article-title":"Measles Immunity Testing: Comparison of Two Measles IgG ELISAs with Plaque Reduction Neutralisation Assay","volume":"131","author":"Cohen","year":"2006","journal-title":"J. Virol. Methods"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1016\/j.vaccine.2011.04.037","article-title":"A Large Observational Study to Concurrently Assess Persistence of Measles Specific B-Cell and T-Cell Immunity in Individuals Following Two Doses of MMR Vaccine","volume":"29","author":"Haralambieva","year":"2011","journal-title":"Vaccine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles Antibody: Reevaluation of Protective Titers","volume":"162","author":"Chen","year":"1990","journal-title":"J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006454-199503000-00007","article-title":"Serologic Status and Measles Attack Rates among Vaccinated and Unvaccinated Children in Rural Senegal","volume":"14","author":"Samb","year":"1995","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archpedi.161.3.294","article-title":"Persistence of Measles Antibodies after 2 Doses of Measles Vaccine in a Postelimination Environment","volume":"161","author":"LeBaron","year":"2007","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of Measles, Mumps, and Rubella Antibodies in an MMR-vaccinated Cohort: A 20-year Follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0264-410X(98)00081-4","article-title":"Vaccine-Induced Measles Virus Antibodies after Two Doses of Combined Measles, Mumps and Rubella Vaccine: A 12-Year Follow-up in Two Cohorts","volume":"16","author":"Davidkin","year":"1998","journal-title":"Vaccine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1016\/j.vaccine.2019.07.049","article-title":"Long-Term Immunogenicity of Measles, Mumps and Rubella-Containing Vaccines in Healthy Young Children: A 10-Year Follow-Up","volume":"37","author":"Carryn","year":"2019","journal-title":"Vaccine"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Seok, H., Espa\u00f1o, E., Kim, J., Jeon, J.H., Choi, W.S., Kim, Y.-K., Kim, J.-K., and Park, D.W. (2022). Immunogenicity after Outbreak Response Immunization Activities among Young Healthcare Workers with Secondary Vaccine Failure during the Measles Epidemic in Korea, 2019. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-022-07511-2"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"ofaa505","DOI":"10.1093\/ofid\/ofaa505","article-title":"Dynamics of the Antibody Response after a Third Dose of Measles-Mumps-Rubella Vaccine Indicate a Slower Decline Compared with a Second Dose","volume":"7","author":"Kaaijk","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kaaijk, P., Wijmenga-Monsuur, A.J., Ten Hulscher, H.I., Kerkhof, J., Smits, G., Nicolaie, M.A., van Houten, M.A., and van Binnendijk, R.S. (2022). Antibody Levels at 3-Years Follow-up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults. Vaccines, 10.","DOI":"10.3390\/vaccines10010132"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.vaccine.2019.02.030","article-title":"Differential Durability of Immune Responses to Measles and Mumps Following MMR Vaccination","volume":"37","author":"Kennedy","year":"2019","journal-title":"Vaccine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0008-8749(75)80002-5","article-title":"Additional Evidence That the Cell-Associated Immune System Is the Primary Host Defense against Measles (Rubeola)","volume":"17","author":"Ruckdeschel","year":"1975","journal-title":"Cell. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/vim.2017.0143","article-title":"Measles Vaccine","volume":"31","author":"Griffin","year":"2018","journal-title":"Viral Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3947\/ic.2019.51.3.305","article-title":"Modified Measles in an Anti-Measles Immunoglobulin G-Negative Healthcare Worker Who Had Received Two Doses of Measles-Containing Vaccine","volume":"51","author":"Park","year":"2019","journal-title":"Infect. Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/cid\/ciu105","article-title":"Outbreak of Measles among Persons with Prior Evidence of Immunity, New York City, 2011","volume":"58","author":"Rosen","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3346\/jkms.2017.32.11.1876","article-title":"An Outbreak of Measles in a University in Korea, 2014","volume":"32","author":"Choe","year":"2017","journal-title":"J. Korean Med. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"ofw064","DOI":"10.1093\/ofid\/ofw064","article-title":"Measles Outbreak Associated with Low Vaccine Effectiveness among Adults in Pohnpei State, Federated States of Micronesia, 2014","volume":"3","author":"Hales","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1080\/21645515.2015.1082014","article-title":"Vaccination of Healthcare Workers: A Review. Hum","volume":"11","author":"Haviari","year":"2015","journal-title":"Vaccin. Immunother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3947\/ic.2019.51.1.54","article-title":"Preliminary Report of Seroprevalence of Anti-Measles Immunoglobulin G among Healthcare Workers of 6 Teaching Hospitals of Daegu, Korea in 2019","volume":"51","author":"Chang","year":"2019","journal-title":"Infect. Chemother."},{"key":"ref_41","first-page":"18-00224","article-title":"Measles Outbreak in a Tertiary Level Hospital, Porto, Portugal, 2018: Challenges in the Post-Elimination Era","volume":"23","author":"Almeida","year":"2018","journal-title":"Eurosurveillance"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/cid\/civ802","article-title":"Healthcare Workers and Post-Elimination Era Measles: Lessons on Acquisition and Exposure Prevention","volume":"62","author":"Gohil","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/21645515.2018.1564442","article-title":"Pre-Vaccination IgG Screening for Mumps Is the Most Cost-Effectiveness Immunization Strategy among Health Care Workers","volume":"15","author":"Coppeta","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/10105395211026468","article-title":"Screening and Vaccination against Measles and Varicella among Health Care Workers: A Cost-Effectiveness Analysis","volume":"33","author":"Lee","year":"2021","journal-title":"Asia Pac. J. Public Health"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1080\/21645515.2020.1871296","article-title":"Long-Term Immunogenicity after Measles Vaccine vs. Wild Infection: An Italian Retrospective Cohort Study","volume":"17","author":"Bianchi","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Anichini, G., Gandolfo, C., Fabrizi, S., Miceli, G.B., Terrosi, C., Gori Savellini, G., Prathyumnan, S., Orsi, D., Battista, G., and Cusi, M.G. (2020). Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy. Vaccines, 8.","DOI":"10.3390\/vaccines8010066"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.3346\/jkms.2020.35.e76","article-title":"A Nationwide Survey on the Hospital Vaccination Policies in Korea","volume":"35","author":"Park","year":"2020","journal-title":"J. Korean Med. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e01472-20","DOI":"10.1128\/JCM.01472-20","article-title":"Measles Vaccine-Associated Rash Illness in China: An Emerging Issue in the Process of Measles Elimination","volume":"58","author":"Cui","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e1546","DOI":"10.1093\/cid\/ciaa1090","article-title":"Adverse Events among Young Adults Following a Third Dose of Measles-Mumps-Rubella Vaccine","volume":"73","author":"Marin","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3947\/ic.2020.52.1.113","article-title":"Review of Measles in Korea: Quarantine and Elimination","volume":"52","author":"Kang","year":"2020","journal-title":"Infect. Chemother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/21645515.2015.1093263","article-title":"Primary vaccine failure to routine vaccines: Why and what to do?","volume":"12","author":"Wiedermann","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0264-410X(98)00017-6","article-title":"The Association between HLA Class I Alleles and Measles Vaccine-Induced Antibody Response: Evidence of a Significant Association","volume":"16","author":"Poland","year":"1998","journal-title":"Vaccine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJM196903202801202","article-title":"Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines","volume":"280","author":"Bellanti","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/apm.12413","article-title":"Comparison of Chemiluminescent Immunoassay and ELISA for Measles IgG and IgM","volume":"123","author":"Minguito","year":"2015","journal-title":"APMIS"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jcv.2015.06.095","article-title":"Immune Status of Health Care Workers to Measles Virus: Evaluation of Protective Titers in Four Measles IgG EIAs","volume":"69","author":"Vreeswijk","year":"2015","journal-title":"J. Clin. Virol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/11\/1812\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:04:35Z","timestamp":1760144675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/11\/1812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":55,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["vaccines10111812"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10111812","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,28]]}}}